139 related articles for article (PubMed ID: 29348651)
21. Differences in prefrontal blood oxygenation during an acute multitasking stressor in ecstasy polydrug users.
Roberts CA; Wetherell MA; Fisk JE; Montgomery C
Psychol Med; 2015 Jan; 45(2):395-406. PubMed ID: 25066866
[TBL] [Abstract][Full Text] [Related]
22. Brain serotonin synthesis in MDMA (ecstasy) polydrug users: an alpha-[(11) C]methyl-l-tryptophan study.
Booij L; Soucy JP; Young SN; Regoli M; Gravel P; Diksic M; Leyton M; Pihl RO; Benkelfat C
J Neurochem; 2014 Dec; 131(5):634-44. PubMed ID: 25041501
[TBL] [Abstract][Full Text] [Related]
23. Association of a functional polymorphism in the serotonin transporter gene with abnormal emotional processing in ecstasy users.
Roiser JP; Cook LJ; Cooper JD; Rubinsztein DC; Sahakian BJ
Am J Psychiatry; 2005 Mar; 162(3):609-12. PubMed ID: 15741482
[TBL] [Abstract][Full Text] [Related]
24. Psychiatric profiles of mothers who take Ecstasy/MDMA during pregnancy: reduced depression 1 year after giving birth and quitting Ecstasy.
Turner JJ; Parrott AC; Goodwin J; Moore DG; Fulton S; Min MO; Singer LT
J Psychopharmacol; 2014 Jan; 28(1):55-61. PubMed ID: 24327452
[TBL] [Abstract][Full Text] [Related]
25. Differential effect of the 5-HTT gene-linked polymorphic region on emotional eating during stress exposure following tryptophan challenge.
Markus CR; Verschoor E; Smeets T
J Nutr Biochem; 2012 Apr; 23(4):410-6. PubMed ID: 21658929
[TBL] [Abstract][Full Text] [Related]
26. Differential effects of tri-allelic 5-HTTLPR polymorphisms in healthy subjects on mood and stress performance after tryptophan challenge.
Markus CR; Firk C
Neuropsychopharmacology; 2009 Dec; 34(13):2667-74. PubMed ID: 19675533
[TBL] [Abstract][Full Text] [Related]
27. Long-term neuronal damage and recovery after a single dose of MDMA: expression and distribution of serotonin transporter in the rat brain.
Kirilly E
Neuropsychopharmacol Hung; 2010 Sep; 12(3):413-23. PubMed ID: 20962361
[TBL] [Abstract][Full Text] [Related]
28. Brain serotonin transporter binding in former users of MDMA ('ecstasy').
Selvaraj S; Hoshi R; Bhagwagar Z; Murthy NV; Hinz R; Cowen P; Curran HV; Grasby P
Br J Psychiatry; 2009 Apr; 194(4):355-9. PubMed ID: 19336788
[TBL] [Abstract][Full Text] [Related]
29. Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use.
Bedi G; Van Dam NT; Redman J
J Psychopharmacol; 2010 Feb; 24(2):233-40. PubMed ID: 18832429
[TBL] [Abstract][Full Text] [Related]
30. Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.
Morgan MJ
Neuropsychopharmacology; 1998 Oct; 19(4):252-64. PubMed ID: 9718589
[TBL] [Abstract][Full Text] [Related]
31. Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function.
Curran HV; Verheyden SL
Psychopharmacology (Berl); 2003 Aug; 169(1):91-103. PubMed ID: 12759801
[TBL] [Abstract][Full Text] [Related]
32. In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users.
Erritzoe D; Frokjaer VG; Holst KK; Christoffersen M; Johansen SS; Svarer C; Madsen J; Rasmussen PM; Ramsøy T; Jernigan TL; Knudsen GM
Arch Gen Psychiatry; 2011 Jun; 68(6):562-76. PubMed ID: 21646575
[TBL] [Abstract][Full Text] [Related]
33. Antidepressant-like effects of ecstasy in subjects with a predisposition to depression.
Majumder I; White JM; Irvine RJ
Addict Behav; 2012 Oct; 37(10):1189-92. PubMed ID: 22704044
[TBL] [Abstract][Full Text] [Related]
34. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems.
Parrott AC; Milani RM; Parmar R; Turner JD
Psychopharmacology (Berl); 2001 Dec; 159(1):77-82. PubMed ID: 11797073
[TBL] [Abstract][Full Text] [Related]
35. The effect of acute tryptophan depletion on mood and impulsivity in polydrug ecstasy users.
Young SN; Regoli M; Leyton M; Pihl RO; Benkelfat C
Psychopharmacology (Berl); 2014 Feb; 231(4):707-16. PubMed ID: 24142202
[TBL] [Abstract][Full Text] [Related]
36. An investigation into the sub-acute effects of ecstasy on aggressive interpretative bias and aggressive mood - are there gender differences?
Hoshi R; Pratt H; Mehta S; Bond AJ; Curran HV
J Psychopharmacol; 2006 Mar; 20(2):291-301. PubMed ID: 16510487
[TBL] [Abstract][Full Text] [Related]
37. Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low.
Curran HV; Travill RA
Addiction; 1997 Jul; 92(7):821-31. PubMed ID: 9293041
[TBL] [Abstract][Full Text] [Related]
38. Early-emerging cognitive vulnerability to depression and the serotonin transporter promoter region polymorphism.
Hayden EP; Dougherty LR; Maloney B; Olino TM; Sheikh H; Durbin CE; Nurnberger JI; Lahiri DK; Klein DN
J Affect Disord; 2008 Apr; 107(1-3):227-30. PubMed ID: 17804080
[TBL] [Abstract][Full Text] [Related]
39. Is emotional intelligence impaired in ecstasy-polydrug users?
Craig L; Fisk JE; Montgomery C; Murphy PN; Wareing M
J Psychopharmacol; 2010 Feb; 24(2):221-31. PubMed ID: 18801831
[TBL] [Abstract][Full Text] [Related]
40. [A case of acute psychotic episode after a single dose of ecstasy].
Vaiva G; Bailly D; Boss V; Thomas P; Lestavel P; Goudemand M
Encephale; 2001; 27(2):198-202. PubMed ID: 11407274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
